B. Riley Comments on Abacus Life's Q2 Earnings (NASDAQ:ABL)

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - Equities research analysts at B. Riley cut their Q2 2025 earnings per share estimates for shares of Abacus Life in a report released on Tuesday, July 15th. B. Riley analyst R. Binner now anticipates that the company will earn $0.17 per share for the quarter, down from their prior estimate of $0.18. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share. B. Riley also issued estimates for Abacus Life's Q3 2025 earnings at $0.20 EPS.

Abacus Life (NASDAQ:ABL - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.18 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.02. The firm had revenue of $44.14 million during the quarter, compared to analyst estimates of $39.51 million. Abacus Life had a positive return on equity of 16.76% and a negative net margin of 13.35%.

A number of other analysts have also commented on the company. Piper Sandler decreased their price objective on Abacus Life from $12.00 to $10.00 and set an "overweight" rating for the company in a report on Wednesday, July 2nd. Maxim Group began coverage on Abacus Life in a report on Tuesday, April 29th. They set a "buy" rating and a $14.00 price objective for the company. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Abacus Life currently has an average rating of "Buy" and an average target price of $13.75.

Abacus Life Stock Down 1.0%

ABL traded down $0.05 during midday trading on Thursday, reaching $5.06. 606,356 shares of the company were exchanged, compared to its average volume of 393,268. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.47 and a current ratio of 0.47. The company's fifty day moving average price is $6.44 and its 200 day moving average price is $7.25. The company has a market cap of $490.06 million and a price-to-earnings ratio of -22.00. Abacus Life has a one year low of $4.60 and a one year high of $11.86.

Hedge Funds Weigh In On Abacus Life

Several institutional investors have recently modified their holdings of the business. Millennium Management LLC grew its holdings in Abacus Life by 1,629.1% during the fourth quarter. Millennium Management LLC now owns 192,019 shares of the company's stock valued at $1,504,000 after purchasing an additional 180,914 shares during the period. Two Sigma Investments LP bought a new position in Abacus Life during the fourth quarter valued at $617,000. Jane Street Group LLC bought a new position in Abacus Life during the fourth quarter valued at $282,000. Renaissance Technologies LLC grew its holdings in Abacus Life by 356.0% during the fourth quarter. Renaissance Technologies LLC now owns 210,500 shares of the company's stock valued at $1,648,000 after purchasing an additional 164,334 shares during the period. Finally, Foundry Partners LLC bought a new position in Abacus Life during the fourth quarter valued at $5,364,000.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.